Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001775394-19-000001
Filing Date
2019-12-04
Accepted
2019-12-04 16:07:13
Documents
1
Effectiveness Date
2019-12-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10090
  Complete submission text file 0001775394-19-000001.txt   11239
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-354771 | Film No.: 191268259
SIC: 2834 Pharmaceutical Preparations